Your browser doesn't support javascript.
loading
[Acquired haemophilia A]. / Verworven hemofilie A.
Brouwer, R E; Huisman, M V; Feuth, J D; van der Meer, F J.
Affiliation
  • Brouwer RE; Afd. Algemene Interne Geneeskunde, Academisch Ziekenhuis, Leiden.
Ned Tijdschr Geneeskd ; 141(27): 1342-4, 1997 Jul 05.
Article in Nl | MEDLINE | ID: mdl-9380188
ABSTRACT
A 74-year-old man developed a severe bleeding disorder on the basis of acquired Factor VIII (F VIII) inhibitor. Coagulation assays showed a prolonged activated partial thromboplastin time (APTT) with a normal prothrombin time (PT);F VIII level was 0.07 IU and F VIII inhibitor level 8.8 Bethesda units (BU). At least half the cases of acquired haemophilia A are associated with pregnancy, the postpartum period or an underlying malignancy or autoimmune disease. Haemorrhagic diathesis can be severe and life-threatening. Treatment of acute haemorrhages consists of human or porcine factor VIII concentrate, activated prothrombin complex concentrate (FEIBA) or recombinant factor VIIa, depending on the antibody titre. Immunosuppressive therapy is successful in at least 60% of the patients in making the inhibitor disappear. In patients with a spontaneous haemorrhagic diathesis, a thorough medical history should be taken, coagulation assays should be performed and a specialist should be consulted.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Factor VIII / Hemophilia A Type of study: Diagnostic_studies Limits: Aged / Humans / Male Language: Nl Journal: Ned Tijdschr Geneeskd Year: 1997 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Factor VIII / Hemophilia A Type of study: Diagnostic_studies Limits: Aged / Humans / Male Language: Nl Journal: Ned Tijdschr Geneeskd Year: 1997 Document type: Article